The Ocular and Gut Microbiome Axis in Understanding Glaucoma: A Systematic Review
Journal of Clinical Medicine · 04.02.2026 · 15 (3) · 1245
DOI: 10.3390/jcm15031245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.02.2026. Verfasst von Bruno Songel-Sanchis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Glaucoma is a neurodegenerative disease and the second leading cause of irreversible blindness in developed countries. It is characterized by progressive loss of retinal ganglion cells (RGCs) and optic nerve axons, leading to permanent vision impairment. Although elevated intraocular pressure (IOP) is the main recognized risk factor, recent evidence suggests that ocular and gut microbiota may play a significant role in the onset and progression of glaucoma.
Objectives
This study aimed to characterize ocular and gut microbiota alterations in patients with different types of glaucoma.
Methods
Five searches were conducted between June and September 2025 using selected keywords. A total of 121 articles were identified, of which 14 met the inclusion criteria following the PRISMA 2020 guidelines.
Results
Findings indicate a Mendelian genetic predisposition influencing microbiota composition associated with glaucoma development. Patients treated with benzalkonium chloride (BAK) showed increased Gram-negative and Alphaproteobacteria on the ocular surface, along with enhanced lipopolysaccharide synthesis. Compared with controls, glaucoma patients exhibited reduced Corynebacterium mastiditis and Actinobacteria and increased Firmicutes, Proteobacteria, and Verrucomicrobiota. Dysbiosis was more pronounced in patients with concurrent dry eye disease, characterized by higher Gram-negative taxa and pro-inflammatory microbial activity.
Conclusions
Significant differences in ocular and gut microbiota were observed between glaucoma patients and controls, as well as among glaucoma subtypes such as pseudoexfoliation and primary open-angle glaucoma. Age-related dysbiosis and epigenetic factors appear to contribute to disease development. Microbiota profiling may offer new opportunities for improved prediction, management, and treatment of glaucoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
- Servicio de Oftalmología, Hospital Clínico San Carlos, Departamento de Inmunología, Oftalmología y Otorrinolaringología, Faculta de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
ORCID-Profile: Bruno Songel-Sanchis, Javier García-Bardera, Noemí Güemes-Villahoz
Zitieren
APA
Songel-Sanchis, B., Morales-Fernández, L., García-Bardera, J., Güemes-Villahoz, N., Martínez-de-la-Casa, J. M., & García-Feijoo, J. (2026). The Ocular and Gut Microbiome Axis in Understanding Glaucoma: A Systematic Review. Journal of Clinical Medicine, 15(3), 1245. https://doi.org/10.3390/jcm15031245
Vancouver
Songel-Sanchis B, Morales-Fernández L, García-Bardera J, Güemes-Villahoz N, Martínez-de-la-Casa JM, García-Feijoo J. The Ocular and Gut Microbiome Axis in Understanding Glaucoma: A Systematic Review. Journal of Clinical Medicine. 2026;15(3):1245. doi:10.3390/jcm15031245
BibTeX
@article{SongelSanchis2026,
author = {Songel-Sanchis, Bruno and Morales-Fernández, Laura and García-Bardera, Javier and Güemes-Villahoz, Noemí and Martínez-de-la-Casa, José María and García-Feijoo, Julián},
title = {The Ocular and Gut Microbiome Axis in Understanding Glaucoma: A Systematic Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {3},
pages = {1245},
doi = {10.3390/jcm15031245}
}
EUVIMED